Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Nasdaq Real Time Price USD

Keurig Dr Pepper Inc. (KDP)

34.04
-0.08
(-0.23%)
At close: May 7 at 4:00:01 PM EDT
34.41
+0.37
+(1.09%)
After hours: May 7 at 6:40:23 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 3.63B
Earnings 568M

Q2'24

Q3'24

Q4'24

Q1'25

0
1B
2B
3B
4B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

34.00
38.62 Average
34.04 Current
42.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 17172020
Avg. Estimate 0.490.542.042.17
Low Estimate 0.470.5122.14
High Estimate 0.510.562.062.21
Year Ago EPS 0.450.511.922.04

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 13131818
Avg. Estimate 4.14B4.12B16.16B16.8B
Low Estimate 4.1B4.07B15.98B16.61B
High Estimate 4.19B4.21B16.39B16.97B
Year Ago Sales 3.92B3.89B15.35B16.16B
Sales Growth (year/est) 5.46%5.92%5.26%4.00%

Earnings History

Currency in USD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. 0.450.510.570.38
EPS Actual 0.450.510.580.42
Difference 000.010.04
Surprise % 0.27%0.79%1.54%9.85%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.490.542.042.17
7 Days Ago 0.490.552.032.18
30 Days Ago 0.490.552.032.18
60 Days Ago 0.490.542.032.17
90 Days Ago 0.490.542.042.18

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --173
Up Last 30 Days ----94
Down Last 7 Days 101017
Down Last 30 Days 101219

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
KDP 8.00%5.56%6.03%6.78%
S&P 500 12.50%3.24%7.95%13.84%

Upgrades & Downgrades

Maintains Barclays: Overweight to Overweight 4/28/2025
Upgrade HSBC: Hold to Buy 4/25/2025
Reiterates RBC Capital: Outperform to Outperform 4/22/2025
Maintains UBS: Buy to Buy 4/17/2025
Initiated Argus Research: Buy 4/16/2025
Upgrade Piper Sandler: Neutral to Overweight 4/9/2025

Related Tickers